Loading live market data…

FibroGen, Inc.

NASDAQ:FGEN

$9.07 USD

-$0.15 (-1.63%)

Volume
29.26K
Average Volume
33.23K
Market Capitalization
$36.69M
P/E Ratio
0.22
Dividend Yield
0.00%
Price Target
$28.00
Year High
$21.95
Year Low
$4.85
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.61
Source Headline

Get FGEN Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

FGEN Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$28.00

1 analysts

FGEN Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-09-24 HC Wainwright & Co. Maintain Buy Buy
2025-08-07 HC Wainwright & Co. Maintain Buy Buy
2025-05-13 HC Wainwright & Co. Maintain Buy Buy
2025-03-18 HC Wainwright & Co. Maintain Buy Buy
2025-02-20 HC Wainwright & Co. Maintain Buy Buy
2023-08-08 B of A Securities Downgrade Neutral Underperform
2023-06-27 Goldman Sachs Maintain Sell Sell
2023-06-27 Raymond James Downgrade Outperform Market Perform
2023-06-26 B of A Securities Downgrade Buy Neutral
2023-06-26 Stifel Downgrade Buy Hold
2023-06-26 William Blair Downgrade Outperform Market Perform
2023-06-26 Raymond James Downgrade Outperform Market Perform
2023-06-02 Stifel Upgrade Hold Buy
2023-02-28 Cowen & Co. Maintain Market Perform Market Perform
2023-02-23 Goldman Sachs Maintain Sell Sell
2023-02-21 Goldman Sachs Maintain Sell Sell
2023-01-31 William Blair Upgrade Market Perform Outperform
2023-01-26 Raymond James Upgrade Market Perform Outperform
2023-01-05 B of A Securities Upgrade Neutral Buy
2022-11-08 Goldman Sachs Maintain Sell Sell
2022-05-24 Goldman Sachs Maintain Sell Sell
2022-03-01 Goldman Sachs Maintain Sell Sell
2021-09-22 Goldman Sachs Downgrade Neutral Sell
2021-08-20 Raymond James Upgrade Underperform Market Perform
2021-08-10 SVB Leerink Maintain Outperform Outperform
2021-07-16 B of A Securities Downgrade Buy Neutral
2021-07-16 Stifel Downgrade Buy Hold
2021-04-07 Mizuho Downgrade Buy Neutral
2021-04-07 SVB Leerink Maintain Outperform Outperform
2021-04-07 JP Morgan Upgrade Underweight Neutral
2021-04-07 HC Wainwright & Co. Downgrade Buy Neutral
2021-03-31 B of A Securities Upgrade Neutral Buy
2021-03-02 Jefferies Downgrade Buy Hold
2021-03-02 SVB Leerink Maintain Outperform Outperform
2020-11-06 SVB Leerink Maintain Outperform Outperform
2020-09-08 SVB Leerink Maintain Outperform Outperform
2020-08-07 SVB Leerink Maintain Outperform Outperform
2020-05-08 SVB Leerink Maintain Outperform Outperform
2019-08-26 Mizuho Maintain Buy Buy
2019-05-10 William Blair Downgrade Outperform Market Perform
2018-12-19 Citigroup Upgrade Neutral Buy
2018-10-15 Leerink Swann Maintain Outperform Outperform
2018-05-15 Mizuho Upgrade Neutral Buy
2017-07-21 Goldman Sachs Downgrade Buy Neutral
2016-02-11 Credit Suisse Upgrade Neutral Outperform
2015-07-20 Goldman Sachs Upgrade Neutral Buy
2015-01-09 Goldman Sachs Downgrade Buy Neutral